• RXO posted Q2 2026 GAAP net loss of $9 million, unchanged from a year earlier; GAAP diluted EPS held at $(0.05).
• Revenue fell 20.01% to $1.42 billion; gross margin slipped 1.98% to $247 million.
• Adjusted EBITDA (non-GAAP) eased 5% to $38 million; adjusted diluted EPS (non-GAAP) rose to $0.06 from $0.04.
• Brokerage volume rose 2% year-over-year, including 2% TL growth; TL spot mix climbed to 42%, up 900 bps sequentially.
• Q3 adjusted EBITDA outlook set at $35 million-$45 million; management said brokerage TL volume improved each month in Q2.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RXO Inc. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.